Cytosorbents (CTSO) Short-term Investments (2014 - 2024)

Cytosorbents' (CTSO) quarterly Short-term Investments came in at $5.0 million in Q4 2024, up 1908.03% on a QoQ basis from $249000.0 in Q2 2016.

Cytosorbents (CTSO) Short-term Investments (2014 - 2024) Analysis & Trends

Cytosorbents (CTSO) has 4 years of Short-term Investments data on file, last reported at $5.0 million in Q4 2024.

Quarterly Short-term Investments changed N/A year-over-year to $5.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $5.0 million (changed N/A YoY) and the FY2024 annual result came in at $5.0 million, changed N/A from the prior year.
Short-term Investments improved to $5.0 million in Q4 2024, from $249000.0 in the prior quarter.
In the past five years, Short-term Investments ranged from a high of $5.0 million in Q4 2024 to a low of $5.0 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Cytosorbents	19.47 Mn	15.06 Mn	7.05 Mn

Download Data